Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01718730 · ClinicalTrials.gov registry record
Cortical Excitability and Inhibition in MDD
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 23
- Enrollment target
NCT01718730: Completed study, sponsored by Mayo Clinic.
NCT01718730 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01718730 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if measures of brain activity are different in children and adolescents with depression who are in different stages of treatment. This is important because it may identify a biological marker for depression that could one day be used to identify depressed children who would benefit from certain treatments (medications for example), or to monitor how well treatments are working. Brain activity measures(known as cortical excitability and inhibition) will be collected by Transcranial Magnetic Stimulation (TMS). TMS is a noninvasive (no surgery or implants) brain stimulation technology which can make parts of the brain work without putting any wires or chemicals into the body. Measurements will take place over one 3-hour visit. This study does not provide any form of treatment. \*There is an optional portion of the study that uses a brain scan to gather measures of brain structure and brain chemicals. The brain scan is called magnetic resonance and spectroscopy (MRI/MRS). MRI/MRS uses magnetic fields to study the structure of the brain and brain chemicals. The PI will determine eligibility for the MRI/MRS portion of the study.
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
- DEVICE Magnetic Resonance Spectroscopy and Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01718730
The ClinicalTrials.gov registry entry for NCT01718730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT01718730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01718730 about?
NCT01718730 is a clinical study titled "Cortical Excitability and Inhibition in MDD". The purpose of this study is to learn if measures of brain activity are different in children and adolescents with depression who are in different stages of treatment. This is important because it may identify a biological marker for depression that could one day be used to identify depressed childr...
What is the current status of trial NCT01718730?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2012-10. Estimated completion is 2019-08.
What interventions are being tested in trial NCT01718730?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE), Magnetic Resonance Spectroscopy and Imaging (DEVICE).
Who is sponsoring clinical trial NCT01718730?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.